Most COVID-19 medical device EUAs lack documented supporting data, JAMA study shows

The use of “low-quality data” is reasonable at the start of a crisis but FDA should consider raising the standard of evidence after multiple products come to market, according to the authors of the study.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: